The News Feed

News

Study Describes Risk Factors for Ocular Complications in HZO

Researchers found that increased age, female sex, steroids at initial visit and stromal involvement were each linked with higher odds of developing further problems.
October 4, 2024

Study Identifies OCT-A Parameters to Predict DME Treatment Response

At baseline, patients who experienced good outcomes on ranibizumab therapy tended to have higher vascular densities in the superficial and deep capillary plexuses and smaller FAZ areas.
October 4, 2024

Researchers Identify Risk Factors for Neovascular Glaucoma After Vein Occlusion

Absence of PVD, Black race, Hispanic ethnicity, diabetic retinopathy and CRVO vs. BRVO incidents are all linked to a higher likelihood. The findings emphasize the importance of early detection and monitoring.
October 4, 2024

Glaucoma Patients Using Alpha Agonists May Have Higher Alzheimer’s Risk

Large study sees a 15% increase in those on the therapy compared with beta-blockers use, which has previously been shown to be protective.
October 3, 2024

Research Uncovers Differences in MNV Response to Anti-VEGF Therapy

Study finds type 2 macular neovascularization decreases more significantly in size and volume over one year of treatment.
October 3, 2024

Be on Guard for Fellow-Eye Disease in PXS

OCT-A could reveal subclinical signs of disease even when slit lamp exam and other methods don’t.
October 3, 2024

Hydroxychloroquine Intake Impacts ONL Thinning

Understanding associations between this medication use and the thinning of retinal regions could serve as an early diagnostic indicator for retinal toxicity.
October 2, 2024

Inverted ILM Flap Best Technique For Macular Atrophy in Myopic Traction Maculopathy

In a new study, half of patients with both diagnoses eventually required surgery, and this procedure conferred a success rate of 94%.
October 2, 2024

OSSN Risk Factors for Development of Limbal Stem Cell Deficiency Identified

Size and severity, as well as recurrence of the malignancy, were all associated with greater odds.
October 2, 2024

Adjuvant Chemo After Enucleation Reduces Recurrence, Improves Survival in Retinoblastoma

Study underscores global discrepancies in defining high-risk histopathology features, calling for a more standardized approach to improve outcomes.
October 1, 2024